No article text was recorded for this version.
acquired resistance induction
Version 2 of 239 papers40 conceptsfrozen 2026-10-04
Papers in this version
- Blog: A novel breast cancer cell line initially established from pleural effusion: Evolution towards a more aggressive phenotype
- Blog: Circ_0061140 knockdown inhibits tumorigenesis and improves PTX sensitivity by regulating miR-136/CBX2 axis in ovarian cancer
- Blog: Alteration in Mir-21/PTEN Expression Modulates Gefitinib Resistance in Non-Small Cell Lung Cancer
- Blog: The tumor suppressor SALL2 opposes chemotherapeutic resistance in breast cancer
- Blog: The Deubiquitinating Enzyme UCHL1 Induces Resistance to Doxorubicin in HER2+ Breast Cancer by Promoting Free Fatty Acid Synthesis
- Blog: FOXM1 contributes to taxane resistance by regulating UHRF1-controlled cancer cell stemness
- Blog: MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin
- Blog: Protein disulfide isomerase family 6 promotes the imatinib-resistance of renal cell carcinoma by regulation of Wnt3a-Frizzled1 axis
- Blog: Long Non-Coding RNA CRNDE is Involved in Resistance to EGFR Tyrosine Kinase Inhibitor in EGFR-Mutant Lung Cancer via eIF4A3/MUC1/EGFR Signaling
- Blog: Branched-Chain Amino Acid Metabolic Reprogramming Orchestrates Drug Resistance to EGFR Tyrosine Kinase Inhibitors
- Blog: Emodin sensitizes the gemcitabine-resistant cell line Bxpc-3/Gem to gemcitabine via downregulation of NF-κB and its regulated targets
- Blog: Targeted Inhibition of miR-221/222 Promotes Cell Sensitivity to Cisplatin in Triple-Negative Breast Cancer MDA-MB-231 Cells
- Blog: Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer
- Blog: IDDF2020-ABS-0201 Targeting hepatoma-intrinsic pparγ signaling overcomes immune checkpoint therapy resistance by inflaming the tumor microenvironment
- Blog: Estrogen receptor-β signaling induces cisplatin resistance in bladder cancer.
- Blog: Decreased DAB2IP gene expression, which could be induced by fractionated irradiation, is associated with resistance to γ-rays and α-particles in prostate cancer cells
- Blog: Accumulation of low-dose BIX01294 promotes metastatic potential of U251 glioblastoma cells
- Blog: Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression
- Blog: Targeting the CtBP1-FOXM1 transcriptional complex with small molecules to overcome MDR1-mediated chemoresistance in osteosarcoma cancer stem cells
- Blog: Antifungal Activity and Multi-Target Mechanism of Action of Methylaervine on Candida albicans
- Blog: Network analysis of an in vitro model of androgen-resistance in prostate cancer
- Blog: Identification and Validation of the Hsa_circ_0001726/miR-140-3p/KRAS Axis in Hepatocellular Carcinoma Based on Microarray Analyses and Experiments
- Blog: Role and Molecular Mechanisms of S100A9 Underlying Gemcitabine Chemoresistance in Bladder Cancer
- Blog: Targeted Inhibition of O-Linked β-N-Acetylglucosamine Transferase as a Promising Therapeutic Strategy to Restore Chemosensitivity and Attenuate Aggressive Tumor Traits in Chemoresistant Urothelial Carcinoma of the Bladder
- Blog: Apatinib inhibits paclitaxel resistance of gastric carcinoma cells through VEGFR2 pathway.
- Blog: LncRNA FOXD3-AS1 promoted chemo-resistance of NSCLC cells via directly acting on miR-127-3p/MDM2 axis
- Blog: Stimulator of interferon response cGAMP interactor overcomes ERBB2-mediated apatinib resistance in head and neck squamous cell carcinoma
- Blog: Curcumin attenuates lncRNA H19‑induced epithelial‑mesenchymal transition in tamoxifen‑resistant breast cancer cells
- Blog: Aquaglyceroporin-7 ameliorates sorafenib resistance and immune evasion in hepatocellular carcinoma through inhibition of lipid accumulation
- Blog: Knockdown of NRMT enhances sensitivity of retinoblastoma cells to cisplatin through upregulation of the CENPA/Myc/Bcl2 axis
- Blog: The FOXM1–ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells
- Blog: Long-term In Vitro Treatment of Human Glioblastoma Cells with Temozolomide Increases Resistance In Vivo through Up-regulation of GLUT Transporter and Aldo-Keto Reductase Enzyme AKR1C Expression
- Blog: Elevated β-catenin pathway as a novel target for patients with resistance to EGF receptor targeting drugs
- Blog: Metabolic Adaptation to Chronic Inhibition of Mitochondrial Protein Synthesis in Acute Myeloid Leukemia Cells
- Blog: Pharmacological targeting of c-FLIPL and Bcl-2 family members promotes apoptosis in CD95L-resistant cells
- Blog: IGF2BP2 Induces U251 Glioblastoma Cell Chemoresistance by Inhibiting FOXO1-Mediated PID1 Expression Through Stabilizing lncRNA DANCR
- Blog: Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma
- Blog: Identifying drivers of breast cancer metastasis in progressively invasive subpopulations of zebrafish-xenografted MDA-MB-231
- Blog: Clinical Implications of iNOS Levels in Triple-Negative Breast Cancer Responding to Neoadjuvant Chemotherapy
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_acquired_resistance_induction_12fb9cf6,
title = {acquired resistance induction},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/acquired-resistance-induction/rdr_12fb9cf6632e456ab8663e08b2bc742b},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-22},
}This exact version (version 2, frozen text):
@misc{lacuna_acquired_resistance_induction_12fb9cf6_v2,
title = {acquired resistance induction},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/acquired-resistance-induction/rdr_12fb9cf6632e456ab8663e08b2bc742b/v/2},
note = {Version 2, frozen 2026-10-04. Accessed 2026-11-22},
}